Usefulness of bevacizumab-induced hypertension in patients with metastatic colorectal cancer: an updated meta-analysis

Chun-Jing Zhang; Shu-Ying Zhang; Chun-Di Zhang; Chun-Rong Lin; Xue-Yan Li; Qiu-Yan Li; Hai-Tao Yu

doi:doi:10.18632/aging.101478

← Back

Research Paper Volume 10, Issue 6 pp 1424—1441

Usefulness of bevacizumab-induced hypertension in patients with metastatic colorectal cancer: an updated meta-analysis

Figure 4. Trial sequential analysis of objective response rate (ORR), progression-free survival (PFS) and overall survival (OS) for bevacizumab-induced hypertension in patients with metastatic colorectal cancer.